- 以下の論文が本年度出ております。
- The Increased Expression of Integrin α6 (ITGA6) Enhances Drug Resistance in EVI1 Leukemia. Yamakawa N, Kaneda K, Saito Y, Ichihara E, Morishita K. PLoS One. 2012;7(1):e30706. Epub 2012 Jan 25.
- Clinical significance of CADM1/TSLC1/IgSF4 expression in adult T-cell leukemia/lymphoma. Nakahata S, Saito Y, Marutsuka K, Hidaka T, Maeda K, Hatakeyama K, Shiraga T, Goto A, Takamatsu N, Asada Y, Utsunomiya A, Okayama A, Kubuki Y, Shimoda K, Ukai Y, Kurosawa G, Morishita K. Leukemia. 2012 Jan 6. [Epub ahead of print]
- Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells. Ichihara E, Kaneda K, Saito Y, Yamakawa N, Morishita K. Biochem Biophys Res Commun. 2011 Dec 16;416(3-4):239-45. Epub 2011 Oct 18.
- Sumoylation of MEL1S at lysine 568 and its interaction with CtBP facilitates its repressor activity and the blockade of G-CSF-induced myeloid differentiation. Nishikata I, Nakahata S, Saito Y, Kaneda K, Ichihara E, Yamakawa N, Morishita K. Oncogene. 2011 Oct 6;30(40):4194-207. Epub 2011 Apr 25.
- CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression. Saito Y, Nakahata S, Yamakawa N, Kaneda K, Ichihara E, Suekane A, Morishita K. Leukemia. 2011 Jun;25(6):921-31.. Epub 2011 Mar 11.
宮崎大学医学部機能制御学講座腫瘍生化学分野
〒889-1692 宮崎県宮崎郡清武町木原5200
TEL：0985-85-0985 FAX：0985-85-2401
Mail: 
MAP